Hospital Motto

Holding a benevolent heart, delivering high-quality medical care, seeking truth, pursuing innovation

Overview
Hospital History
Leadership
Awards & Honors
Newsroom
Location & Maps
Contact Us

Hospital Motto

Holding a benevolent heart, delivering high-quality medical care, seeking truth, pursuing innovation

Departments & Centers
Find a Doctor
How to schedule my visit
Insurance Partner & Charge List
Women's Healthcare

Hospital Motto

Holding a benevolent heart, delivering high-quality medical care, seeking truth, pursuing innovation

Overview
News And Information
Notice Announcement
Education Management
Overseas Exchanges
Teaching Staff

Hospital Motto

Holding a benevolent heart, delivering high-quality medical care, seeking truth, pursuing innovation

Overview
Invetigators
Research Team
Institutes
Paper Chase
Patents
Clinical Trials

Hospital Motto

Holding a benevolent heart, delivering high-quality medical care, seeking truth, pursuing innovation

Overview
Cooperative Partners
Guest Professors
Contact Us

Wang Xin-yu

Title:

Vice President
Chief Physician, the Department of Gynecologic Oncology
Postgraduate Supervisor of Gynecology and Obstetrics, Zhejiang University School of Medicine

Bio:

Education:

2011-2014  Zhejiang University School of Medicine  Doctor Degree in Gynecologic Oncology

1994-1998  Zhejiang University School of Medicine  Master Degree in Gynecologic Oncology

1985-1990  Zhejiang University School of Medicine  Bachelor Degree

 

Expertise:

Gynecologic Oncology

 

Research Interests

The pathogenesis and prevention of cervical cancer

 

Research Narrative:

Dr. Wang has published more than 30 papers on gynecological tumor and participated in edition of Obstetrics and Gynecology (9th edition). She has won 3 provincial science and technology progress awards, and obtained 2 national invention patents.

 

Publication:

1.Songfa Zhang, Xinyu Wang, Zhi-Qin Fu, Qiao-HuaPeng, Jian-Yang Zhang , Feng Ye , Yun-Feng Fu , Cai-Yun Zhou, Wei-Guo Lu, Xiao-Dong Cheng, Xing Xie. TXNDC17 promotes paclitaxel-resistance via inducing autophagy in ovarian cancerAutophagy 2015,Feb,11:2,225-238Co-first author

2.Xu J, Fang Y, Wang X, Wang F, Tian Q, Li Y, Xie X, Cheng X, Lu W.CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis.Oncotarget. 2016 May 24;7(21):31520-33.

3.Tian Q, Lu B, Ye J, Lu W, Xie X, Wang X. Early stage primary ovarian mucinous carcinoma: Outcome-based clinic opathological study in comparison with serous carcinoma.J Int Med Res. 2016 Apr;44(2):357-66.

4.Dou Y, Zhang X, Li Y, Wang F, Xie X, Wang X. Triage for management of cervical high-grade squamous intraepithelial lesion patients with positive margin by conization: a retrospective analysis.Front Med. 2017 Jun;11(2):223-228.

5. Zhang X, Dou Y, Wang M, Li Y, Wang F, Xie X, Wang X.A retrospective analysis on 1901 women with high grade cervical intraepithelial neoplasia by colposcopic biopsy.Eur J ObstetGynecolReprod Biol. 2017 Jul 5;217:53-58.

6. Pan Z, Wang X, Zhang X, Chen X, Xie X. A retrospective analysis on coexisting ovarian cancer in 976 patients with clinical stage I endometrial carcinoma. J. Obstet. Gynaecol. Res. 2011, 37(4):352-8

7. Xinyu Wang,Yajuan Fu, Xiaoduan Chen, Jing Ye, Bingjian Lu, Feng Ye, WeiguoLu,XingXie. The expressions of bHLH gene HES1 and HES5 in advanced ovarian serous adenocarcinomas and their prognostic significance: a retrospective clinical study  J Cancer Res ClinOncol 2010 136(7):989-996

8. Ding T, Wang X, Ye F, Cheng X, Lu W, Xie X. Distribution of human papillomavirus 16 E6/e7 variants in cervical cancer and intraepithelial neoplasia in Chinese women.Int J Gynecol Cancer. 2010 Nov;20(8):1391-8.

9. Ding T, Wang X, Ye F, Cheng X, Ma D, Lu W, XieX. Distribution of human papillomavirus 58 and 52 E6/E7 variants in cervical neoplasia in Chinese women.Gynecol Oncol. 2010 Dec;119(3):436-43.

 

Personal Homepage:

https://person.zju.edu.cn/en/5192001


Purpose

Providing high-quality healthcare for women and children

LEARN MORE